Raj, R.; Kumar, A.; Prachi Sood; Kumar, R.; Rana, V. Randomized Phase III Trial Comparing Epirubicin Doxorubicin Plus Docetaxel and Epirubicin Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer. J. Res. Appl. Sci. Biotechnol. 2023, 2, 55-63.